Literature DB >> 22859701

Components of depression in Parkinson disease.

Laura B Zahodne1, Michael Marsiske, Michael S Okun, Dawn Bowers.   

Abstract

Depression is a clinically heterogeneous disorder common in Parkinson disease (PD). The goal of this study was to characterize PD depression in terms of components, including negative affect, apathy, and anhedonia. Ninety-five, nondemented individuals with idiopathic PD underwent a diagnostic interview and psychological battery. Twenty-seven patients (28%) met Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition [DSM-IV]) criteria for a current depressive episode. The best-fitting confirmatory factor analysis model had 3 factors (negative affect, apathy, and anhedonia). Apathy loaded most strongly onto a second-order factor representing global psychological disturbance. All factors are uniquely associated with depression status. Negative affect exhibited the strongest relationship. Psychological disturbance in PD is heterogeneous and can produce symptoms of apathy, anhedonia, and negative affect. Apathy appears to be the core neuropsychiatric feature of PD, whereas negative affect (eg, dysphoria) seems to be most pathognomonic of depression. Future studies should examine the specific neural correlates and treatment response patterns unique to these 3 components.

Entities:  

Mesh:

Year:  2012        PMID: 22859701      PMCID: PMC3490054          DOI: 10.1177/0891988712455236

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  41 in total

1.  Specificity of affective and autonomic symptoms of depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; A W Forrester; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

Review 3.  Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung.

Authors:  Alan B Shafer
Journal:  J Clin Psychol       Date:  2006-01

4.  Risk factors for depression in Parkinson disease.

Authors:  E Tandberg; J P Larsen; D Aarsland; K Laake; J L Cummings
Journal:  Arch Neurol       Date:  1997-05

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  Depression and Parkinson's disease.

Authors:  Matthias R Lemke; Gerd Fuchs; Irene Gemende; Birgit Herting; Christian Oehlwein; Heinz Reichmann; Jürgen Rieke; Jens Volkmann
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

7.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

Authors:  S E Starkstein; H S Mayberg; T J Preziosi; P Andrezejewski; R Leiguarda; R G Robinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

8.  Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects.

Authors:  T S Ehmann; R J Beninger; M J Gawel; R J Riopelle
Journal:  J Geriatr Psychiatry Neurol       Date:  1990 Jan-Mar       Impact factor: 2.680

9.  Depression in Parkinson's disease: a quantitative and qualitative analysis.

Authors:  A M Gotham; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

10.  Application of depression criteria (DSM-IV) in patients with Parkinson's disease.

Authors:  Juan Carlos Gómez-Esteban; Beatriz Tijero; Johanne Somme; Iker Bilbao; Julen Fernández; Sabas Boyero; Fernando Velasco; Elena Lezcano; J J Zarranz
Journal:  Clin Neurol Neurosurg       Date:  2009-07-08       Impact factor: 1.876

View more
  7 in total

1.  Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.

Authors:  Jesús Pérez-Pérez; Javier Pagonabarraga; Saül Martínez-Horta; Ramón Fernández-Bobadilla; Salvador Sierra; Berta Pascual-Sedano; Alexandre Gironell; Jaime Kulisevsky
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

Review 2.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  Hedonic deficits in Parkinson's disease: is consummatory anhedonia specific?

Authors:  Gwenolé Loas; Cécile Duru; Olivier Godefroy; Pierre Krystkowiak
Journal:  Front Neurol       Date:  2014-03-10       Impact factor: 4.003

4.  Prevalence of depression in Parkinson's disease patients in Ethiopia.

Authors:  Dawit Kibru Worku; Yared Mamushet Yifru; Douglas G Postels; Fikre Enquselassie Gashe
Journal:  J Clin Mov Disord       Date:  2014-12-12

5.  Influence of depressive symptoms on dopaminergic treatment of Parkinson's disease.

Authors:  Alexandru Hanganu; Clotilde Degroot; Oury Monchi; Christophe Bedetti; Béatriz Mejia-Constain; Anne-Louise Lafontaine; Sylvain Chouinard; Marie-Andrée Bruneau
Journal:  Front Neurol       Date:  2014-09-25       Impact factor: 4.003

6.  Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease.

Authors:  Jalal Shakeri; Maryam Chaghazardi; Nasrin Abdoli; Farid Arman; Seyed Davood Hoseini; Hania Shakeri
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

Review 7.  Dopamine System Dysregulation in Major Depressive Disorders.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.